Ziv I - Search Results

1

Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of action.

Achiron A, Gilad R, Margalit R, Gabbay U, Sarova-Pinhas I, Cohen IR, Melamed E, Lider O, Noy S, Ziv I. Achiron A, et al. Among authors: ziv i. J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):57-61. doi: 10.1136/jnnp.57.suppl.57. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964856 Free PMC article.

2

Aphasia in multiple sclerosis: clinical and radiologic correlations.

Achiron A, Ziv I, Djaldetti R, Goldberg H, Kuritzky A, Melamed E. Achiron A, et al. Among authors: ziv i. Neurology. 1992 Nov;42(11):2195-7. doi: 10.1212/wnl.42.11.2195. Neurology. 1992. PMID: 1436535

3

Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis.

Achiron A, Pras E, Gilad R, Ziv I, Mandel M, Gordon CR, Noy S, Sarova-Pinhas I, Melamed E. Achiron A, et al. Among authors: ziv i. Arch Neurol. 1992 Dec;49(12):1233-6. doi: 10.1001/archneur.1992.00530360031013. Arch Neurol. 1992. PMID: 1449400

4

Lymphocyte ultrastructure in patients with multiple sclerosis.

Djaldetti R, Achiron A, Ziv I, Djaldetti M. Djaldetti R, et al. Among authors: ziv i. Biomed Pharmacother. 1995;49(6):300-3. doi: 10.1016/0753-3322(96)82647-3. Biomed Pharmacother. 1995. PMID: 7579012

5

IL-3-LA production by mononuclear cells of patients with multiple sclerosis: effect of treatment with intravenous immunoglobulins.

Djaldetti R, Achiron A, Ziv I, Djaldetti M, Melamed E, Fishman P. Djaldetti R, et al. Among authors: ziv i. Immunol Invest. 1995 Aug;24(5):765-73. doi: 10.3109/08820139509060704. Immunol Invest. 1995. PMID: 8543340

6

Fatigue in multiple sclerosis compared with chronic fatigue syndrome: A quantitative assessment.

Djaldetti R, Ziv I, Achiron A, Melamed E. Djaldetti R, et al. Among authors: ziv i. Neurology. 1996 Mar;46(3):632-5. doi: 10.1212/wnl.46.3.632. Neurology. 1996. PMID: 8618658

7

Short-term beneficial effect of deprenyl monotherapy in early Parkinson's disease: a quantitative assessment.

Ziv I, Achiron A, Djaldetti R, Dressler R, Melamed E. Ziv I, et al. Clin Neuropharmacol. 1993 Feb;16(1):54-60. doi: 10.1097/00002826-199302000-00006. Clin Neuropharmacol. 1993. PMID: 8422657

8

Dopamine-induced, genotoxic activation of programmed cell death. A role in nigrostriatal neuronal degeneration in Parkinson's disease?

Ziv I, Barzilai A, Offen D, Stein R, Achiron A, Melamed E. Ziv I, et al. Adv Neurol. 1996;69:229-33. Adv Neurol. 1996. PMID: 8615132 Review. No abstract available.

9

Gastric emptying in Parkinson's disease: patients with and without response fluctuations.

Djaldetti R, Baron J, Ziv I, Melamed E. Djaldetti R, et al. Among authors: ziv i. Neurology. 1996 Apr;46(4):1051-4. doi: 10.1212/wnl.46.4.1051. Neurology. 1996. PMID: 8780089

10

Levodopa--an exotoxin or a therapeutic drug?

Melamed E, Offen D, Shirvan A, Ziv I. Melamed E, et al. Among authors: ziv i. J Neurol. 2000 Apr;247 Suppl 2:II135-9. doi: 10.1007/pl00022914. J Neurol. 2000. PMID: 10991660 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters